paracetamol

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:drug
analgesic
antipyretic
gptkbp:ATCCode N02BE01
gptkbp:bioavailability 63–89% (oral)
gptkbp:brand gptkb:Tylenol
gptkb:Acetaminophen
gptkb:Panadol
gptkbp:CASNumber 103-90-2
gptkbp:category non-opioid analgesic
essential medicine
antipyretic
gptkbp:chemicalFormula C8H9NO2
gptkbp:commonDosageForm gptkb:sugar
gptkb:tablet
capsule
injection
suppository
gptkbp:contraindication severe liver disease
gptkbp:discoveredBy gptkb:Harmon_Northrop_Morse
gptkbp:discoveredIn 1877
gptkbp:eliminationHalfLife 1–4 hours
gptkbp:excretion urine
gptkbp:foundIn combination drugs
gptkbp:halfLife 1–4 hours (adults)
https://www.w3.org/2000/01/rdf-schema#label paracetamol
gptkbp:IUPACName N-(4-hydroxyphenyl)acetamide
gptkbp:legalStatus OTC (over-the-counter)
gptkbp:marketedAs 1950s
gptkbp:maximumDailyDose 4 grams (adults)
gptkbp:mechanismOfAction inhibits prostaglandin synthesis
gptkbp:meltingPoint 169°C
gptkbp:metabolism gptkb:NAPQI
gptkb:paracetamol_glucuronide
gptkb:paracetamol_sulfate
liver
gptkbp:overdoseTreatment gptkb:acetylcysteine
gptkbp:pregnancyCategory B (US)
A (Australia)
gptkbp:prescriptionStatus OTC in most countries
gptkbp:proteinBinding 10–25%
gptkbp:riskOfOverdose hepatotoxicity
gptkbp:routeOfAdministration oral
intravenous
rectal
gptkbp:sideEffect liver damage (in overdose)
gptkbp:solubility 14 mg/mL (20°C)
gptkbp:synonym acetaminophen
gptkbp:usedFor pain relief
fever reduction
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:Essential_Medicines
gptkbp:bfsLayer 5